The modern landscape of neurodegenerative therapeutics is defined by an urgent, ongoing quest for disease-modifying interventions capable of altering the destructive trajectory of progressive cognitive decline and dementia. Among these conditions, Alzheimer’s disease stands out as a devastating pathology driven by the abnormal accumulation of extracellular amyloid-beta plaques, intracellular neurofibrillary tangles composed of hyperphosphorylated tau […]